Page last updated: 2024-10-30

lorazepam and Craniocerebral Injuries

lorazepam has been researched along with Craniocerebral Injuries in 2 studies

Lorazepam: A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent.

Research Excerpts

ExcerptRelevanceReference
" Additional pharmacokinetic investigations are recommended to optimise pharmacological outcomes in patients with severe head injury."2.40Pharmacokinetic alterations after severe head injury. Clinical relevance. ( Boucher, BA; Hanes, SD, 1998)
"Antipyrine clearance was increased significantly from baseline (0."1.28Effect of neurotrauma on hepatic drug clearance. ( Boucher, BA; Fabian, TC; Kuhl, DA; Robertson, JT, 1991)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boucher, BA2
Hanes, SD1
Kuhl, DA1
Fabian, TC1
Robertson, JT1

Reviews

1 review available for lorazepam and Craniocerebral Injuries

ArticleYear
Pharmacokinetic alterations after severe head injury. Clinical relevance.
    Clinical pharmacokinetics, 1998, Volume: 35, Issue:3

    Topics: Aminopyrine; Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants; Blood-Brain Barrier; Cranioce

1998

Other Studies

1 other study available for lorazepam and Craniocerebral Injuries

ArticleYear
Effect of neurotrauma on hepatic drug clearance.
    Clinical pharmacology and therapeutics, 1991, Volume: 50, Issue:5 Pt 1

    Topics: Adult; Aged; Antipyrine; C-Reactive Protein; Craniocerebral Trauma; Humans; Indocyanine Green; Liver

1991